JPS6223725B2 - - Google Patents

Info

Publication number
JPS6223725B2
JPS6223725B2 JP13768678A JP13768678A JPS6223725B2 JP S6223725 B2 JPS6223725 B2 JP S6223725B2 JP 13768678 A JP13768678 A JP 13768678A JP 13768678 A JP13768678 A JP 13768678A JP S6223725 B2 JPS6223725 B2 JP S6223725B2
Authority
JP
Japan
Prior art keywords
fluorouracil
anticancer
compound
thymidine
fluorouracils
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP13768678A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5564518A (en
Inventor
Setsuo Fujii
Norio Saimi
Setsuo Takeda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taiho Pharmaceutical Co Ltd
Original Assignee
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiho Pharmaceutical Co Ltd filed Critical Taiho Pharmaceutical Co Ltd
Priority to JP13768678A priority Critical patent/JPS5564518A/ja
Priority to GB7908960A priority patent/GB2016921B/en
Priority to CH272679A priority patent/CH639274A5/de
Priority to FR7907523A priority patent/FR2420974A1/fr
Priority to IT67629/79A priority patent/IT1119283B/it
Priority to DE2912112A priority patent/DE2912112C2/de
Publication of JPS5564518A publication Critical patent/JPS5564518A/ja
Priority to US06/552,263 priority patent/US4650801A/en
Priority to US06/932,516 priority patent/US4914105A/en
Publication of JPS6223725B2 publication Critical patent/JPS6223725B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP13768678A 1978-03-27 1978-11-07 Carcinostatic composition Granted JPS5564518A (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
JP13768678A JPS5564518A (en) 1978-11-07 1978-11-07 Carcinostatic composition
GB7908960A GB2016921B (en) 1978-03-27 1979-03-14 Anti cancer compositions containing uracil derivatives
CH272679A CH639274A5 (de) 1978-03-27 1979-03-23 Antikrebsmittel.
FR7907523A FR2420974A1 (fr) 1978-03-27 1979-03-26 Medicament a base de derives de l'uracile
IT67629/79A IT1119283B (it) 1978-03-27 1979-03-27 Composizione anti cancro
DE2912112A DE2912112C2 (de) 1978-03-27 1979-03-27 Antikrebs-Präparat
US06/552,263 US4650801A (en) 1978-03-27 1983-11-16 Anti-cancer compositions for delivering 5-fluorouracil
US06/932,516 US4914105A (en) 1978-03-27 1986-11-20 Anti-cancer compositions for delivering 5-fluorouracil

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP13768678A JPS5564518A (en) 1978-11-07 1978-11-07 Carcinostatic composition

Publications (2)

Publication Number Publication Date
JPS5564518A JPS5564518A (en) 1980-05-15
JPS6223725B2 true JPS6223725B2 (en, 2012) 1987-05-25

Family

ID=15204428

Family Applications (1)

Application Number Title Priority Date Filing Date
JP13768678A Granted JPS5564518A (en) 1978-03-27 1978-11-07 Carcinostatic composition

Country Status (1)

Country Link
JP (1) JPS5564518A (en, 2012)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998055493A1 (fr) * 1997-06-03 1998-12-10 Mori, Takahide Substances naturelles antitumorales ou antivirales et leur utilisation

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998055493A1 (fr) * 1997-06-03 1998-12-10 Mori, Takahide Substances naturelles antitumorales ou antivirales et leur utilisation

Also Published As

Publication number Publication date
JPS5564518A (en) 1980-05-15

Similar Documents

Publication Publication Date Title
RU2214238C2 (ru) Фармацевтическая композиция, обладающая противоопухолевым действием со сниженными побочными эффектами, содержащая противоопухолевый агент и производное гидроксамовой кислоты
IL255465A (en) Albocidiv drug enhancers with improved bioavailability
US20070293468A1 (en) Anticancer compositions, and methods of making and using the same
JP2019515884A5 (en, 2012)
CN101107001A (zh) 配合有α,α,α-三氟胸苷和胸苷磷酸化酶抑制剂的抗癌剂
JPH0430924B2 (en, 2012)
AU2004220205B2 (en) Antitumor effect potentiator and antitumor agent
JP2951407B2 (ja) チアゾフリン及びリバビリンを用いる新生物病の処置方法
JP2557303B2 (ja) 抗腫瘍効果増強剤及び抗腫瘍剤
JP2688057B2 (ja) 抗腺がん剤
JP3982889B2 (ja) イブプロフェン含有医薬製剤
NL194430C (nl) Niet-injecteerbaar farmaceutisch preparaat met anti-kankerwerking.
US5534513A (en) Antitumor potentiator and antitumor composition
JPS6223725B2 (en, 2012)
HUP0203790A2 (hu) (6-Metoxi-2-naftil)-ecetsav prodrugokat tartalmazó gyógyszerkészítmények alkalmazása gyulladás kezelésére
US3169091A (en) Process for inhibiting tumors with substituted pyrazoles
JPH0120128B2 (en, 2012)
JPS6231689B2 (en, 2012)
EA006776B1 (ru) Фармацевтическая композиция для лечения диабетической невропатии
JPS6257165B2 (en, 2012)
JPS6223723B2 (en, 2012)
JPS6213924B2 (en, 2012)
JPH03502802A (ja) 抗嘔吐性エルゴリン誘導体
JPS6231690B2 (en, 2012)
AU609835B2 (en) Antidiabetic agent